🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess whether postoperative adjuvant thera...
Status
Active Not Recruiting
Location
University of Arizona
Start Date
2019-07-18
Trial ID
NCT03897881
Treatments Being Tested
The goal of this study is to learn if people who receive intismeran autogen...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0181)
Start Date
2024-10-21
Trial ID
NCT06623422
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Active Not Recruiting
Location
Angeles Clinic and Research Institute
Start Date
2017-08-14
Trial ID
NCT03313778
Treatments Being Tested
Researchers want to know if intismeran autogene (the study treatment) given...
Status
Recruiting
Location
Moffitt Cancer Center ( Site 0021)
Start Date
2025-12-12
Trial ID
NCT07221474
Treatments Being Tested
This is a two-part (Phase 2/Phase 3) study of intismeran autogene, an indiv...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center ( Site 1112)
Start Date
2024-04-18
Trial ID
NCT06295809
Treatments Being Tested
Researchers want to learn if intismeran autogene with pembrolizumab can sto...
Status
Recruiting
Location
Highlands Oncology Group ( Site 4042)
Start Date
2025-05-29
Trial ID
NCT06961006
Treatments Being Tested
Researchers are looking for new ways to treat people with high-risk non-mus...
Status
Recruiting
Location
Michael G Oefelein Clinical Trials ( Site 0138)
Start Date
2025-03-11
Trial ID
NCT06833073
Treatments Being Tested
The primary objective of the study is to compare intismeran autogene plus p...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center-Medical Oncology ( Site 0104)
Start Date
2024-04-10
Trial ID
NCT06307431
Treatments Being Tested
Researchers are looking for new ways to treat high-risk, localized non-smal...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center ( Site 3204)
Start Date
2026-05-04
Trial ID
NCT07513376
Treatments Being Tested
The goal of this study is to evaluate intismeran autogene plus pembrolizuma...
Status
Recruiting
Location
Alaska Oncology and Hematology ( Site 0039)
Start Date
2023-12-06
Trial ID
NCT06077760
Treatments Being Tested